...
search icon
annx-img

Annexon Inc Share Price

ANNX
NSQ
$5.145
+$0.1
(1.98%)
1D
Industry: Biotechnology Sector: Health Care

Annexon Inc Analyst Forecast

Annexon Inc Share Price Chart

Annexon Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$751.24M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
363.82K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.14
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.28 L
$7.18 H
$5.145

About Annexon Inc, Common Stock

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company's lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. The company is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California. more

Industry: BiotechnologySector: Health Care

Annexon Inc Stock Returns

Time FrameANNXSectorS&P500
1-Week Return-10.16%1.31%-1.33%
1-Month Return-18.18%1.27%0.78%
3-Month Return66.89%3.74%2.61%
6-Month Return114.47%15.81%6.19%
1-Year Return86.67%8.89%11.68%
3-Year Return-15.29%19.23%67.81%
5-Year Return-82.71%35.04%74.06%
10-Year Return-71.62%136.97%255.08%

Annexon Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue667.00K3.41M3.31M3.27M3.45M[{"date":"2020-12-31","value":19.31,"profit":true},{"date":"2021-12-31","value":98.84,"profit":true},{"date":"2022-12-31","value":95.86,"profit":true},{"date":"2023-12-31","value":94.59,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit(667.00K)(3.41M)(3.31M)(3.27M)(3.45M)[{"date":"2020-12-31","value":-66700000,"profit":false},{"date":"2021-12-31","value":-341400000,"profit":false},{"date":"2022-12-31","value":-331100000,"profit":false},{"date":"2023-12-31","value":-326700000,"profit":false},{"date":"2024-12-31","value":-345400000,"profit":false}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses63.47M130.71M145.60M143.72M150.62M[{"date":"2020-12-31","value":42.14,"profit":true},{"date":"2021-12-31","value":86.78,"profit":true},{"date":"2022-12-31","value":96.67,"profit":true},{"date":"2023-12-31","value":95.42,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(63.47M)(130.71M)(145.60M)(143.72M)(154.07M)[{"date":"2020-12-31","value":-6346900000,"profit":false},{"date":"2021-12-31","value":-13071300000,"profit":false},{"date":"2022-12-31","value":-14559900000,"profit":false},{"date":"2023-12-31","value":-14372300000,"profit":false},{"date":"2024-12-31","value":-15407300000,"profit":false}]
Total Non-Operating Income/Expense114.00K780.00K7.30M19.17M31.75M[{"date":"2020-12-31","value":0.36,"profit":true},{"date":"2021-12-31","value":2.46,"profit":true},{"date":"2022-12-31","value":23.01,"profit":true},{"date":"2023-12-31","value":60.37,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(63.41M)(130.32M)(141.95M)(134.24M)(138.20M)[{"date":"2020-12-31","value":-6341200000,"profit":false},{"date":"2021-12-31","value":-13032300000,"profit":false},{"date":"2022-12-31","value":-14194700000,"profit":false},{"date":"2023-12-31","value":-13423700000,"profit":false},{"date":"2024-12-31","value":-13820000000,"profit":false}]
Income Taxes(667.00K)(2.53M)(3.65M)--[{"date":"2020-12-31","value":-66700000,"profit":false},{"date":"2021-12-31","value":-253100000,"profit":false},{"date":"2022-12-31","value":-365200000,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(62.74M)(127.79M)(138.29M)--[{"date":"2020-12-31","value":-6274500000,"profit":false},{"date":"2021-12-31","value":-12779200000,"profit":false},{"date":"2022-12-31","value":-13829500000,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(63.41M)(130.71M)(145.60M)(140.73M)(138.20M)[{"date":"2020-12-31","value":-6341200000,"profit":false},{"date":"2021-12-31","value":-13071300000,"profit":false},{"date":"2022-12-31","value":-14559900000,"profit":false},{"date":"2023-12-31","value":-14072900000,"profit":false},{"date":"2024-12-31","value":-13820000000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(62.74M)(127.79M)(138.29M)(134.24M)(138.20M)[{"date":"2020-12-31","value":-6274500000,"profit":false},{"date":"2021-12-31","value":-12779200000,"profit":false},{"date":"2022-12-31","value":-13829500000,"profit":false},{"date":"2023-12-31","value":-13423700000,"profit":false},{"date":"2024-12-31","value":-13820000000,"profit":false}]
EPS (Diluted)(33.44)(3.40)(2.87)(1.78)(1.02)[{"date":"2020-12-31","value":-3344,"profit":false},{"date":"2021-12-31","value":-340,"profit":false},{"date":"2022-12-31","value":-287,"profit":false},{"date":"2023-12-31","value":-178,"profit":false},{"date":"2024-12-31","value":-102,"profit":false}]

Annexon Inc Ratios

Annexon Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

ANNX
Cash Ratio 4.33
Current Ratio 4.42

Annexon Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ANNX
ROA (LTM) -44.95%
ROE (LTM) -83.99%

Annexon Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ANNX
Debt Ratio Lower is generally better. Negative is bad. 0.30
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.70

Annexon Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ANNX
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 4.51
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Annexon Inc share price today?

Annexon Inc (ANNX) share price today is $5.145

Can Indians buy Annexon Inc shares?

Yes, Indians can buy shares of Annexon Inc (ANNX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ANNX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Annexon Inc be purchased?

Yes, you can purchase fractional shares of Annexon Inc (ANNX) via the Vested app. You can start investing in Annexon Inc (ANNX) with a minimum investment of $1.

How to invest in Annexon Inc shares from India?

You can invest in shares of Annexon Inc (ANNX) via Vested in three simple steps:

  • Click on Sign Up or Invest in ANNX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Annexon Inc shares
What is Annexon Inc 52-week high and low stock price?

The 52-week high price of Annexon Inc (ANNX) is $7.18. The 52-week low price of Annexon Inc (ANNX) is $1.28.

What is Annexon Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Annexon Inc (ANNX) is

What is Annexon Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Annexon Inc (ANNX) is 4.51

What is Annexon Inc dividend yield?

The dividend yield of Annexon Inc (ANNX) is 0.00%

What is the Market Cap of Annexon Inc?

The market capitalization of Annexon Inc (ANNX) is $751.24M

What is Annexon Inc's stock symbol?

The stock symbol (or ticker) of Annexon Inc is ANNX

How Can Investors Use Annexon Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Annexon Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Annexon Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Annexon Inc shares for Indian investors?

When investing in Annexon Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Annexon Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Annexon Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Annexon Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Annexon Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top